Mondaq Latin America: Food, Drugs, Healthcare, Life Sciences
Moeller IP Advisors
The ANMAT has launched a public consultation aimed at simplifying the registration of almost 30 pharmaceutical active ingredients. The list includes both nonprescription, referred to as "over-the-counter"...
Moeller IP Advisors
Beginning April 7, 2016, the registration of food products before the INAL, a division of the ANMAT, can only be made electronically through the Federal Information System for Food Control Management.
Moeller IP Advisors
The Bolivian PTO (National Service of Intellectual Property – SENAPI) recently organized a workshop with national and international experts aimed at outlining technical guidelines...
TozziniFreire Advogados
On November 23 2016 the Health Surveillance Agency (ANVISA) approved changes to its rules for using substances subject to special control in order to provide easier access to drugs containing cannabidiol...
TozziniFreire Advogados
On November 23 2016 the Health Surveillance Agency (ANVISA) approved changes to its rules for using substances subject to special control in order to provide easier access to drugs containing CBD...
Moeller IP Advisors
On March 22, 2016, the Brazilian Health Authority (ANVISA) approved the amendments of Regulation RDC 48/2009, which refers to the post-approval changes of drug products.
Moeller IP Advisors
The Brazilian National Health Surveillance Authority (Anvisa) signed a cooperation project with the Republic of El Salvador through the local regulatory agency for medicine...
Moeller IP Advisors
According to an analysis of data from the Brazilian Health Surveillance Agency performed the Medical Device Consulting EMERGO, Brazilian regulators for the medical device market have reduced timeframes in 2015...
Moeller IP Advisors
According to the recent statistics released by the Brazilian Health Surveillance Agency (ANVISA), 742 medicines were registered in Brazil in 2015, a 105 percent overall increase over 2014.
Carey
Pharmaceutical company Pfizer's Chilean subsidiary has agreed behavioural remedies as part of a settlement with Chile's National Economic Prosecutor...
Moeller IP Advisors
The Directorate of Drugs and Biological Products of the Colombian MoH– now requires the pharmaceutical drug industry to submit the corresponding Unique Drug Identifier...
Moeller IP Advisors
The Mexican Health Authority (COFEPRIS) has recently signed joint declarations with Germany and Denmark to promote and strengthen the cooperation and exchange of good practices regarding health risks.
Moeller IP Advisors
The head of the Federal Commission for Protection against Health Risks, Julio Sanchez y Tépoz, met with a delegation of Korean government representatives to help strengthen the communication...
Moeller IP Advisors
In February 2016, Mexico updated its regulations 059 and 164 regarding the GMP of drugs and active pharmaceutical products with the goal of joining the Pharmaceutical Inspection Cooperation Scheme.
Moeller IP Advisors
The Peruvian PTO administrators of the Designation of Origin Pisco and the Regulatory Council of Pisco are working together to reinforce the administration of the DO Pisco by means of modifying, . . .
Moeller IP Advisors
The World Bank's International Centre for Settlement of Investment Disputes ruled in favor of Uruguay, ordering Philip Morris International to cover Uruguay's legal fees, in excess of $7 million.
M & M Bomchil
On January 13th, 2017, the Official Gazette of Buenos Aires City published Law No. 5709, which aims to provide patients a tool that allows them to have as much information as possible about conflicts...
Moeller IP Advisors
Fake drugs impact so many aspects of society, it is hard to really wrap your arms around the problem. Public health, law enforcement, hospitals, drugstores and yes, even large pharma conglomerates.
Moeller IP Advisors
The US Food and Drug Administration (FDA) is warning of several safety issues regarding opioid analgesics.
Moeller IP Advisors
Health agencies of Mexico, Spain, Colombia, Paraguay and Central America, signed a letter of intent aiming to strengthen joint surveillance on the sale of medicines over the Internet and reduce health risk.
Most Popular Recent Articles
TozziniFreire Advogados
On November 23 2016 the Health Surveillance Agency (ANVISA) approved changes to its rules for using substances subject to special control in order to provide easier access to drugs containing CBD...
TozziniFreire Advogados
On November 23 2016 the Health Surveillance Agency (ANVISA) approved changes to its rules for using substances subject to special control in order to provide easier access to drugs containing cannabidiol...
Moeller IP Advisors
Fake drugs impact so many aspects of society, it is hard to really wrap your arms around the problem. Public health, law enforcement, hospitals, drugstores and yes, even large pharma conglomerates.
Brokering Abogados
Medical devices are any instrument, apparatus, application, material or article, including software, used by themselves or in tandem, and defined by the manufacturer to be used directly on human beings.
M & M Bomchil
On January 13th, 2017, the Official Gazette of Buenos Aires City published Law No. 5709, which aims to provide patients a tool that allows them to have as much information as possible about conflicts...
Alfaro-Abogados
Argentina's National Drug, Food and Medical Technology Administration (ANMAT) has issued a resolution forbidding the use of antibacterial substances in products for personal hygiene...
Clarke, Modet & Co
14 years after the publication of the reforms that establish the linkage system between the IMPI and the COFEPRIS, there are still doubts in the application and operation of the system...
Global Advertising Lawyers Alliance (GALA)
As in most countries, Brazil has strict regulations on sensitive advertising, especially as regards to alcohol, tobacco and other controlled substances.
Moeller IP Advisors
The Directorate of Drugs and Biological Products of the Colombian MoH– now requires the pharmaceutical drug industry to submit the corresponding Unique Drug Identifier...
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter